Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine hydrochloride sodium chloride injection for monitored anesthesia care sedation
CTR20181762Phase 3Completed
- Sponsor
- Sichuan Guorui Pharmaceutical
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in procedural sedation and analgesia (PSA), sponsored by Sichuan Guorui Pharmaceutical. Started Oct 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on CTR20181762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181762.